Press release
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market is Expected to Reach US$3.8 bn by 2020
Obtain Report Details @ https://www.transparencymarketresearch.com/hospital-acquired-pneumonia-drugs.html
Unlike generally acquired infections and pneumonia, hospital acquired infections are highly resistant to conventional drugs. This creates major problems for patients who are already under treatment for other ailments. Hospital acquired pneumonia usually shows immunity to multiple drugs. It usually becomes a case of comorbidity, drastically reducing a weaker patient’s chances of recovering.
According to the report, there are six drugs currently in the final phases (phase III) of the global hospital acquired pneumonia market pipeline. Of these, five are investigational drugs while another is a vaccine. These are considered to be the leading answers to curbing the high prevalence of hospital acquired pneumonia. Moreover, there are ten other drugs in the early stages of the global hospital acquired pneumonia market pipeline.
As stated in the report, the six phase III drugs in the global hospital acquired pneumonia market pipeline are Tedizolid phosphate by Cubist Pharmaceuticals, Amikacin inhale by Bayer Healthcare, Ceftolozane/tazobactam, Synflorix by GSK, Plazomicin by Achaogen, Inc., and Ceftazidime/avibactam by AstraZeneca PLC.
With a maintenance of schedules, these six drugs are expected to be available in 2017, if they are approved.
Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1881
One of the major trends visible in the global hospital acquired pneumonia market is the shift in preference from conventional antibiotic drugs to the modern, novel biological drugs. This can be noticed in the fact that most of the final stage drugs in the global hospital acquired pneumonia market pipeline are biological drugs.
The report also takes up citations from the U.S. CDC, according to which at least 63% of the variants of acinetobacter are resistant to multiple drugs. Meanwhile, the most prominent MRSA was the most dangerous and prominent organism associated with hospital acquired pneumonia. The CDC had also revealed that nearly 11,000 of the 80,400 patients who contracted MRSA-based HAIs had died.
The WHO adds to this with a study that revealed low income and medium income families to be the most susceptible to HAIs. These factors need to be considered by the global hospital acquired pneumonia market in the development of new drugs.
Purchase this Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=1881<ype=S
The key players in the global hospital acquired pneumonia market pipeline for now, include the companies named above. For the overall global hospital acquired pneumonia market, the report takes into consideration the player profiles of Basilea Pharmaceutica Ltd., Meiji Seika Pharma Co. Ltd., Cubist Pharmaceutical, Valneva SE., Aridis Pharmaceutical, Bayer Healthcare, GlaxoSmithKline, Merck & Co., Achaogen, Inc., and AstraZeneca PLC.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market is Expected to Reach US$3.8 bn by 2020 here
News-ID: 877526 • Views: …
More Releases from Transparency Market Research
Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion …
The global opioid induced constipation (OIC) treatment market is witnessing steady and sustained growth as healthcare systems worldwide place increasing emphasis on comprehensive pain management and supportive care. Valued at US$ 2.9 billion in 2025, the market is projected to reach US$ 5.2 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Growth is primarily fueled by the rising prevalence of chronic…
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product T …
The global Pneumatic Flux Chipper Market is set to witness sustained and resilient growth over the next decade, underpinned by expanding heavy manufacturing activities, rising welding and fabrication demand, and continuous investments in industrial infrastructure across emerging and developed economies. According to the latest industry analysis, the market was valued at US$ 760.5 Mn in 2025 and is projected to reach US$ 1,680.8 Mn by 2036, expanding at a compound…
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Bil …
The AI in automotive market is entering a phase of exponential expansion, supported by rapid digitization of vehicles, growing safety mandates, and consumer demand for intelligent mobility. The global market was valued at US$ 19.8 Bn in 2025 and is projected to reach US$ 244.4 Bn by 2036, registering a remarkable CAGR of 27% from 2026 to 2036.
This growth trajectory reflects the transition of automobiles from mechanically driven products to…
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable …
The global hypodermic needles market was valued at approximately US$ 4.2 billion in 2025 and is projected to reach around US$ 7.9 billion by 2036, expanding at a CAGR of nearly 5.8% from 2026 to 2036, driven by the rising prevalence of diabetes, cancer, and chronic diseases, growing demand for injectable drugs and biologics, and the expansion of global vaccination and immunization programs; increasing adoption of safety-engineered and disposable needles,…
More Releases for Hospital
Hip Replacement hospital in LB Nagar | Anvik Hospital
**Total Hip Replacement Surgery at Anvik Hospitals: A Path to Pain-Free Living**
Total Hip Replacement (THR) is a transformative surgical procedure that alleviates chronic pain and restores mobility for individuals suffering from debilitating hip joint conditions. At Anvik Hospitals, we pride ourselves on offering advanced hip replacement solutions that are designed to provide long-lasting relief and significantly improve joint function, allowing patients to regain their quality of life.
### Understanding Total Hip…
Medical Tourism Market Detailed In New Research Report 2024 | Mission Hospital, …
Medical Tourism Market Trends Overview 2024-2031:
A new Report by Coherent Market Insights, titled "Medical Tourism Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Medical Tourism market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful…
Beyond Pet Care: The Modern Veterinary Hospital Experience | All Pets Veterinary …
Veterinary Hospital Market 2023 Forecast: Unveiling Opportunities and Growth
Veterinary Hospital market report presents an overview of the market on the basis of key parameters such as market size, revenue, sales analysis and key drivers. The market size of global Veterinary Hospital market is anticipated to grow at large scale over the forecast period (2023-2029). The main purpose of the study report is to give users an extensive viewpoint of the…
Outpatient Surgical Procedures Market 2023 | Futuristic Trends- Hornsby Ku-ring- …
The Outpatient Surgical Procedures research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Outpatient Surgical Procedures research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force.
Download FREE Sample Report…
Global Hospital Furniture Market by Type (Hospital Bed, Hospital Chair & Bench, …
Report Overview
The size of the global market for hospital furniture was evaluated at USD 9.11 billion in 2022, and it is expected to rise at a CAGR of 6.8% from 2023 to 2032. The market is expanding as a result of reasons including the rising number of hospital admissions worldwide, attractive insurance and payment scenarios, and government support for hospitals included in the healthcare industry. In addition, the incidence of…
Canada Hospital Supplies Market Report - Disposable Hospital Supplies, Hospital …
ReportsnReports added a new report on The Canada Hospital Supplies Market report that delivers the clean elaborated structure of the Report comprising each and every business-related information of the market at a global level. The in-depth study on the current state which focuses on the major drivers and restraints for the key players. Canada Hospital Supplies Market Industry research report provides granular analysis of the market share, segmentation, revenue forecasts,…
